Endocrinology and Metabolism Unit, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia di Udine Udine, Italy.
Front Endocrinol (Lausanne). 2011 Aug 19;2:20. doi: 10.3389/fendo.2011.00020. eCollection 2011.
Histological distinction between typical and atypical bronchopulmonary carcinoids is based on mitotic activity and necrosis. Regardless of these two parameters, outcome after surgery is often unpredictable. In this study the prognostic value of different clinico-pathological factors was retrospectively analyzed in a large series of patients with bronchopulmonary carcinoid.
The long-term post-surgical outcome of 106 radically treated patients affected by bronchopulmonary carcinoid from two Italian centers was correlated with tumor characteristics assessed by combining conventional histology with a panel of immunohistochemical markers of neuroendocrine differentiation (chromogranin-A, NSE) and proliferation activity (Ki-67 score).
Carcinoids were assessed as typical (TC = 75; 70.8%) and atypical (AC = 31; 29.2%). Mean follow-up was 8.3 years (range: 0-20; median: 8.0). All cases expressed neuroendocrine markers. At univariate analysis, tumor recurrence [14/75 TC (18.7%), 15/31 AC (48.4%)] correlated with carcinoid histotype (P = 0.003), tumor size (P = 0.012), mitotic index (P = 0.044), Ki-67 score (P < 0.0001), and synchronous node metastasis (P = 0.037). Of these, Cox multivariate analysis confirmed only Ki-67 score as independent predictor of disease recurrence (P = 0.009). The best cut-off for Ki-67 score (calculated by ROC curves) discriminating recurrent vs non-recurrent disease was 4% (sensitivity 79.3%; specificity 83.8%; area under the curve 0.85). By stratifying patients according to this cut-off, a significantly different disease-free survival was found (log-rank test P < 0.0001).
Ki-67 score accurately separates bronchopulmonary carcinoids in two well-distinct histo-prognostic categories. Ki-67 score predicts the patients outcome better than mitotic count, histotype, and tumor stage and it is therefore helpful in establishing the appropriate follow-up.
典型和非典型支气管肺类癌的组织学区分基于有丝分裂活性和坏死。无论这两个参数如何,手术后的结果往往是不可预测的。在这项研究中,回顾性分析了两个意大利中心的大系列支气管肺类癌患者的不同临床病理因素的预后价值。
结合常规组织学和神经内分泌分化的免疫组化标志物(嗜铬粒蛋白 A、NSE)和增殖活性(Ki-67 评分)的panel,分析了 106 例接受根治性治疗的支气管肺类癌患者的长期术后结果与肿瘤特征的相关性。
类癌被评估为典型(TC=75;70.8%)和非典型(AC=31;29.2%)。平均随访时间为 8.3 年(范围:0-20;中位数:8.0)。所有病例均表达神经内分泌标志物。单因素分析显示,肿瘤复发[75 例 TC 中的 14 例(18.7%),31 例 AC 中的 15 例(48.4%)]与类癌组织类型相关(P=0.003),肿瘤大小(P=0.012),有丝分裂指数(P=0.044),Ki-67 评分(P<0.0001)和同步淋巴结转移(P=0.037)。其中,Cox 多因素分析仅证实 Ki-67 评分是疾病复发的独立预测因子(P=0.009)。通过 ROC 曲线计算 Ki-67 评分的最佳截断值(cutoff),可区分复发和非复发疾病,截断值为 4%(敏感性 79.3%;特异性 83.8%;曲线下面积 0.85)。根据该截断值对患者进行分层,发现无疾病生存差异有统计学意义(log-rank 检验 P<0.0001)。
Ki-67 评分准确地将支气管肺类癌分为两个明显不同的组织预后类别。Ki-67 评分比有丝分裂计数、组织类型和肿瘤分期更能预测患者的预后,因此有助于确定适当的随访。